Sadie Whittaker, PhD is the new Chief Scientific Officer of Solve ME/CFS Initiative.
She received her PhD in molecular biology at University of Birmingham, UK, and her BSc in Biochemistry from University of Leeds, UK. Sadie has many of experience in the biotech industry, in clinical development for biologic medicines, and in strategic leadership roles for advocacy, policy, communication, and external engagement. Sadie brings to the organization a deep understanding of the scientific discovery, drug development, and drug commercialization processes, as well as extensive experience in engaging members of the healthcare community. To learn more about Dr. Whittaker, please visit our
staff webpage.
In-between her travels to the Invest in ME research conference in London, Dr. Whittaker took the time to respond to your questions about her work and approach.
